Mashaly Mervat, Kheir Mohamed Abo El, Ibrahim Mohamed, Khafagy Wael
MD, Assistant Professor, Clinical Pathology Department, Clinical Microbiology Unit, Faculty of Medicine, Mansoura University, El Gomhoryia Street, Mansoura, 35516, Egypt.
MD, Professor, General Surgery Department, Faculty of Medicine, Mansoura University, Mansoura, 35516, Egypt.
Germs. 2021 Dec 29;11(4):570-582. doi: 10.18683/germs.2021.1292. eCollection 2021 Dec.
Diabetic foot infection (DFI) is one of the common diabetic complications. Pathogens causing DFI and their antibiotic susceptibility vary with location. Therefore, empirical antibiotic therapy should be based on the pathogens that are most likely to be present. Aim: To identify the frequent aerobic bacteria causing DFI with detection of their antibiotic susceptibility to help clinicians in our community choose the best empirical antibiotic for DFI.
Swabs were collected from 104 diabetic foot ulcers (DFUs). Aerobic bacterial cultures were done followed by bacterial identification and antibiotic susceptibility testing on VITEK® 2 system. Extended-spectrum beta-lacatamase (ESBL) detection was performed phenotypically and confirmed by multiplex-PCR for , and genes.
Aerobic bacterial infection was detected in 82/104 (78.8%) of the DFUs. Gram-negative bacilli (GNB) were isolated more frequently (56.1%) than Gram-positive cocci (GPC) (43.9%). The most common single-isolated bacteria were (26.8%), and coagulase negative staphylococci (22% for each). The only significant independent predictors of DFI with GNB or GPC were long DM duration and frequent hospitalizations, respectively. The most active antibiotics were amikacin, tigecycline and meropenem for GNB, and linezolid and vancomycin for staphylococci. Multidrug-resistance prevalence was 95.1%. ESBL was detected in 52.6% of Enterobacteriaceae; the gene was the most common (90%), followed by (65%) and (35%). Peripheral neuropathy was the single independent predictor for DFI with ESBL producers (adjusted OR=15.5).
There is a notable local pattern of DFI bacteriology in our community. Our findings could be valuable in developing the future empirical treatment guidelines for DFIs.
糖尿病足感染(DFI)是常见的糖尿病并发症之一。引起DFI的病原体及其抗生素敏感性因感染部位而异。因此,经验性抗生素治疗应基于最可能存在的病原体。目的:通过检测引起DFI的常见需氧菌及其抗生素敏感性,以帮助我们社区的临床医生为DFI选择最佳的经验性抗生素。
从104例糖尿病足溃疡(DFU)中采集拭子。进行需氧菌培养,随后在VITEK® 2系统上进行细菌鉴定和抗生素敏感性测试。采用表型方法检测超广谱β-内酰胺酶(ESBL),并通过多重聚合酶链反应对 、 和 基因进行确认。
在104例DFU中,82例(78.8%)检测到需氧菌感染。革兰氏阴性杆菌(GNB)的分离频率(56.1%)高于革兰氏阳性球菌(GPC)(43.9%)。最常见的单一分离菌是 (26.8%)、 和凝固酶阴性葡萄球菌(各占22%)。DFI合并GNB或GPC的唯一显著独立预测因素分别是糖尿病病程长和频繁住院。对GNB最有效的抗生素是阿米卡星、替加环素和美罗培南,对葡萄球菌最有效的是利奈唑胺和万古霉素。多重耐药率为95.1%。在52.6%的肠杆菌科细菌中检测到ESBL; 基因最常见(90%),其次是 (65%)和 (35%)。周围神经病变是DFI合并ESBL产生菌的唯一独立预测因素(校正比值比=15.5)。
我们社区存在显著的DFI细菌学局部模式。我们的研究结果可能对制定未来DFI的经验性治疗指南有价值。